Zobrazeno 1 - 10 of 350 pro vyhledávání: '"Goetsch, U."'
1
Akademický článek
Investigation of an airport-associated cluster of falciparum malaria in Frankfurt, Germany, 2022.
Autor: Kessel J; Goethe University, University Hospital Frankfurt, Department of Infectious Diseases, Frankfurt, Germany., Rosanas-Urgell A; Unit of Malariology, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium., Dingwerth T; Medical Center Frankfurt, Medical Services & Health Management Lufthansa Group, Frankfurt, Germany., Goetsch U; Municipal Health Protection Authority, Frankfurt, Germany., Haller J; Goethe University, Department of Integrative parasitology and animal physiology, Frankfurt, Germany.; Municipal Health Protection Authority, Frankfurt, Germany., Huits R; Department of Infectious Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Verona, Italy., Kattenberg JH; Unit of Malariology, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium., Meinecke A; Hannover Medical School, Department of Rheumatology and Immunology, Hannover, Germany., Monsieurs P; Unit of Malariology, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium., Sroka M; Fraport AG, Medical Services, Frankfurt, Germany., Witte T; Hannover Medical School, Department of Rheumatology and Immunology, Hannover, Germany., Wolf T; Goethe University, University Hospital Frankfurt, Department of Infectious Diseases, Frankfurt, Germany.
Publikováno v: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2024 Feb; Vol. 29 (5).
Zobrazit plný text záznamu
2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
3
Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies
Autor: Wilhelm, A., Widera, M., Grikscheit, K., Toptan, T., Schenk, B., Pallas, C., Metzler, M., Kohmer, N., Hoehl, S., Marschalek, R., Herrmann, E., Helfritz, F.A., Wolf, T., Goetsch, U., Ciesek, Sandra
Background: In recent months, Omicron variants of SARS-CoV-2 have become dominant in many regions of the world, and case numbers with Omicron subvariants BA.1 and BA.2 continue to increase. Due to numerous mutations in the spike protein, the efficacy
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______610::500a56688a116c11706a6f82ce9b87f8
https://publica.fraunhofer.de/handle/publica/430784
Zobrazit plný text záznamu
4
Akademický článek
Comparison of the Ct-values for genomic and subgenomic SARS-CoV-2 RNA reveals limited predictive value for the presence of replication competent virus.
Autor: Roesmann F; Institute for Medical Virology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Sandhofstr. 2-4, House 75, Room 1.207, Frankfurt am Main 60528, Germany., Jakobsche I; Institute for Medical Virology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Sandhofstr. 2-4, House 75, Room 1.207, Frankfurt am Main 60528, Germany., Pallas C; Institute for Medical Virology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Sandhofstr. 2-4, House 75, Room 1.207, Frankfurt am Main 60528, Germany., Wilhelm A; Institute for Medical Virology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Sandhofstr. 2-4, House 75, Room 1.207, Frankfurt am Main 60528, Germany., Raffel J; Institute for Medical Virology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Sandhofstr. 2-4, House 75, Room 1.207, Frankfurt am Main 60528, Germany., Kohmer N; Institute for Medical Virology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Sandhofstr. 2-4, House 75, Room 1.207, Frankfurt am Main 60528, Germany., Toptan T; Institute for Medical Virology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Sandhofstr. 2-4, House 75, Room 1.207, Frankfurt am Main 60528, Germany., Berger A; Institute for Medical Virology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Sandhofstr. 2-4, House 75, Room 1.207, Frankfurt am Main 60528, Germany., Goetsch U; Health Protection Authority, Frankfurt am Main, Germany., Ciesek S; Institute for Medical Virology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Sandhofstr. 2-4, House 75, Room 1.207, Frankfurt am Main 60528, Germany; German Center for Infection Research, DZIF, Braunschweig, Germany; Branch Translational Medicine and Pharmacology, Fraunhofer Institute for Molecular Biology and Applied Ecology (IME), Frankfurt am Main, Germany., Widera M; Institute for Medical Virology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Sandhofstr. 2-4, House 75, Room 1.207, Frankfurt am Main 60528, Germany. Electronic address: marek.widera@kgu.de.
Publikováno v: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology [J Clin Virol] 2023 Aug; Vol. 165, pp. 105499. Date of Electronic Publication: 2023 May 29.
Zobrazit plný text záznamu
5
Akademický článek
Occurrence of extrapulmonary tuberculosis is associated with geographical origin: spatial characteristics of the Frankfurt TB cohort 2013-2018.
Autor: Wetzstein N; Department of Internal Medicine, Infectious Diseases, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany. nils.wetzstein@kgu.de., Drummer AP; Department of Internal Medicine, Infectious Diseases, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany., Bockey A; Department for Epidemiology, Helmholtz Centre for Infection Research, Braunschweig, Germany., Herrmann E; Institute of Biostatistics and Mathematical Modeling, Goethe University, Frankfurt am Main, Germany., Küpper-Tetzel CP; Department of Internal Medicine, Infectious Diseases, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany., Graf C; Department of Internal Medicine, Gastroenterology and Hepatology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany., Koch B; Department of Internal Medicine, Nephrology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany., Goetsch U; Health Protection Authority, City of Frankfurt, Frankfurt am Main, Germany., Vehreschild MJGT; Department of Internal Medicine, Infectious Diseases, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany., Guglielmetti L; Laboratoire de Bactériologie-Hygiène, Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux, APHP, Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié-Salpêtrière, Paris, France.; Sorbonne Université, INSERM, U1135, Centre d'Immunologie et des Maladies Infectieuses, Cimi-Paris, Paris, France., Lange B; Department for Epidemiology, Helmholtz Centre for Infection Research, Braunschweig, Germany., Wichelhaus TA; Institute of Medical Microbiology and Infection Control, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany., Stephan C; Department of Internal Medicine, Infectious Diseases, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.
Publikováno v: Infection [Infection] 2023 Jun; Vol. 51 (3), pp. 679-687. Date of Electronic Publication: 2022 Oct 01.
Zobrazit plný text záznamu
6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
8
Akademický článek
Is Olfactory Testing a Useful Diagnostic Tool to Identify SARS-CoV-2 Infections Early? A Cross-Sectional and Longitudinal Analysis.
Autor: Graf C; Institute of Medical Virology, University Hospital Frankfurt, 60306 Frankfurt am Main, Germany.; Department of Internal Medicine I, University Hospital Frankfurt, 60306 Frankfurt am Main, Germany., Wagener I; Institute of Medical Virology, University Hospital Frankfurt, 60306 Frankfurt am Main, Germany., Grikscheit K; Institute of Medical Virology, University Hospital Frankfurt, 60306 Frankfurt am Main, Germany., Hoehl S; Institute of Medical Virology, University Hospital Frankfurt, 60306 Frankfurt am Main, Germany., Berger A; Institute of Medical Virology, University Hospital Frankfurt, 60306 Frankfurt am Main, Germany., Wetzstein N; Department of Internal Medicine II, Infectious Diseases, University Hospital Frankfurt, 60306 Frankfurt am Main, Germany., Dietz J; Department of Internal Medicine I, University Hospital Frankfurt, 60306 Frankfurt am Main, Germany., Dultz G; Department of Internal Medicine I, University Hospital Frankfurt, 60306 Frankfurt am Main, Germany., Michael F; Department of Internal Medicine I, University Hospital Frankfurt, 60306 Frankfurt am Main, Germany., Filmann N; Institute of Biostatistics and Mathematical Modeling, Goethe University, 60323 Frankfurt am Main, Germany., Herrmann E; Institute of Biostatistics and Mathematical Modeling, Goethe University, 60323 Frankfurt am Main, Germany., Tinnemann P; Public Health Department of the City of Frankfurt am Main, 60306 Frankfurt am Main, Germany., Goetsch U; Public Health Department of the City of Frankfurt am Main, 60306 Frankfurt am Main, Germany., Ciesek S; Institute of Medical Virology, University Hospital Frankfurt, 60306 Frankfurt am Main, Germany.; German Centre for Infection Research, Deutsches Zentrum für Infektionsforschung, External Partner Site Frankfurt, 60306 Frankfurt am Main, Germany.
Publikováno v: Journal of clinical medicine [J Clin Med] 2023 Apr 27; Vol. 12 (9). Date of Electronic Publication: 2023 Apr 27.
Zobrazit plný text záznamu
9
Limited Neutralization of Authentic Severe Acute Respiratory Syndrome Coronavirus 2 Variants Carrying E484K in Vitro
Autor: Widera, M., Wilhelm, A., Hoehl, S., Pallas, C., Kohmer, N., Wolf, T., Rabenau, H.F., Corman, V.M., Drosten, C., Vehreschild, M.J.G.T., Goetsch, U., Gottschalk, R., Ciesek, S.
Whether monoclonal antibodies are able to neutralize severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern has been investigated using pseudoviruses. In this study we show that bamlanivimab, casirivimab, and imdevimab effic
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______610::8e4b84fdb867dd32bf8e0120e37421e8
https://publica.fraunhofer.de/handle/publica/416166
Zobrazit plný text záznamu
10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje